50242-143 : Actemra Actpen 180 mg/ml Subcutaneous Injection, Solution
NDC: | 50242-143 |
Labeler: | Genentech, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Actemra Actpen |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA125472 |
Rev. Date: |
NDC Package Codes:
- 50242-143-01: 1 SYRINGE, GLASS IN 1 BOX (50242‑143‑01) > .9 ML IN 1 SYRINGE, GLASS
- 50242-143-86: 1 SYRINGE, GLASS IN 1 BOX (50242‑143‑86) > .9 ML IN 1 SYRINGE, GLASS
Active Ingredients:
- Tocilizumab
Dosage Strength:
- 180 mg/mL
Pharmaceutical Classes:
- Interleukin 6 Receptor Antagonists [MoA]
- Interleukin-6 Receptor Antagonist [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 50242-142Next: 50242-145 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.